Medicares Uncovered Costs Three Basic Expenses That Could Exceed 100000 Annually AlphaSense Highlights 10 Major Mergers and Acquisitions Shaping 2025 SpaceX Successfully Launches Starship Test Flight on Second Attempt Advancing Reusable Rocket Technology Devon Energy Invests 26 Billion to Expand Delaware Basin Presence US Tariff Policy May Moderate Trade Representative Hints at Lower but Persistent Barriers Iran Emerges Stronger in Geopolitical Standoff Analysts Suggest AKR Q1 2026 Earnings Earnings Beat by Wide Margin Despite Minor Stock Decline GBTG Q1 2026 Earnings Strong EPS Beat Amidst Operational Focus CICB Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Beneficient BENF Q1 2026 Earnings Massive EPS Beat on Positive Net Income but Shares Slide Saratoga Investment Corp SAY Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions REZI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline NPFD Edges Higher as Investors Steady Holdings Nuveen Variable Rate Preferred Income Fund NPFD Analysis RIME Surges 826 Algorhythm Holdings Tests Key Resistance at 078 PennantPark Floating Rate Capital PFLT Edges Higher Amid Stable Trading Volume NexPoint Residential Trust NXRT Modest Gains Signal Potential Stabilization Near Support White Mountains Insurance Holds Steady Above 2100 as Modest Gains Persist Oil Prices Slide 5 as Trump Signals Constructive Iran Talks GPMT Q1 2026 Earnings Narrower Loss Surprises Estimates as Mortgage REIT Works Through Portfolio Challenges Hippo Holdings HIPO Retreats 25 as Shares Grapple With Resistance Ceiling Bluejay Diagnostics Inc BJDX Q4 2023 Earnings EPS Misses Estimates by a Wide Margin Amid Continued Operational Challenges EQBK Q1 2026 Earnings EPS Misses Estimates by 32 Shares Dip Slightly PROG Holdings Q1 2026 Earnings Massive EPS Beat Drives Investor Caution Despite Strong Performance ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline BranchOut Food Inc BOF Q1 2026 Earnings Wider Loss Reported as Revenue Remains Undisclosed SPNT Q1 2026 Earnings Earnings Surpass Estimates by 178 Despite Slight Stock Decline ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline